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Subclinical thyroid disease is common, particularly in the middle-aged and the elderly. 
There is mounting evidence to suggest that subclinical thyroid dysfunctions may 
contribute to significant clinical conditions. Symptoms often develop unnoticed and 
therefore identifying thyroid disease clinically can sometimes be difficult. Thyroid 
dysfunction is common in adulthood, but is also present in childhood, although the 
incidence has been considered to be low (1). Thyroid hormone plays an important role 
as a regulator of nervous system myelination, growth and puberty, metabolism, and 
organ functions. Although subclinical hypo- and hyperthyroidism in young people has 
not been widely studied, it is very important to identify thyroid dysfunctions due to the 
influence on growth and development during childhood and adolescence. Previous 
studies have shown that serum thyroid-stimulating hormone (TSH) level is useful for 
determining the prevalence of abnormal thyroid dysfunction in a general population (2). 
Loviselli et al. also showed that antithyroid antibody is associated with an increased 
prevalence of subclinical hypothyroidism in schoolchildren (3). Therefore, it is also 
important to investigate the prevalence of the antithyroid antibodies, 
antithyroperoxidase antibody (TPOAb) and antithyroglobulin antibody (TGAb), 
among this age group. In the present study, we examined the serum TSH level and the 




The subjects were 2,111 children and young adults (750 males and 1,361 
females, 6-22 years of age) examined from 1998 to 2006 at Bryansk 
Consultative-Diagnosis Center, located in Klincy City, Bryansk Oblast. Serum TSH 
levels were measured with an Amerlite hormone analyzer (Amersham, Bunkyo-ku, 
Tokyo, Japan) using commercial assay kits. The normal concentration of TSH was 
between 0.4 and 4.0 U/ml. Titers of TPOAb and TGAb were determined by the 
electrochemiluminescence immunoassay using commercial assay kits (Fujirebio, 
Tokyo). Each prevalence of positive TPOAb and TGAb were evaluated by χ2 test. All 
statistical analysis was performed using SPSS Statistics 18.0 software (SPSS Japan, 
Tokyo, Japan). Probability values less than 0.05 were considered indicative of 
statistical significance. 
The prevalence of positive TPOAb in study participants divided by serum 
TSH concentration is shown in Fig. 1. In females, the prevalence of TPOAb was 
significantly higher both in TSH concentrations less than 0.4 U/ml (P = 0.02) and in 
TSH concentrations more than 4.0 U/ml (P = 0.01) than in normal serum TSH 
concentrations. On the other hand, there were no significant differences in males (P = 
0.14 and P = 0.64, respectively). The prevalence of positive TGAb in study 
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participants divided by serum TSH concentration is shown in Fig. 2. In females, the 
prevalence of TGAb was significantly higher in TSH concentrations less than 0.4 
U/ml, than in normal serum TSH concentrations (P = 0.043), although not in TSH 
concentrations more than 4.0 U/ml (P = 0.14). Moreover, there were no significant 
differences in males (P = 0.56 and P = 0.15, respectively).  
We showed that there is a sex difference in prevalences of TPOAb and TGAb 
among abnormal TSH concentrations. In those of the United States population 12 years 
of age or older, TSH 0.4 U/ml was associated with positive TPOAb but not with 
positive TGAb (4). Loviselli et al. showed that the prevalence of positive antithyroid 
antibody was significantly higher in children with serum TSH greater than 5.0 U/ml 
when compared to that found in children with normal serum TSH (0.2-5.0 U/ml) (3). 
Kaloumenou et al. reported that girls 5-18 years of age with increased TSH values had 
increased positive TPOAb levels as compared to those with normal TSH values 
(0.3-5.0 U/ml). Moreover, there was a significant difference in the prevalence of 
TGAb in girls with increased TSH compared to normal TSH values. On the other hand, 
there was no significant difference in the prevalence of TPOAb or TGAb in boys 
between increased and normal TSH values (5). In children 16 years of age or younger, 
positive TPOAb and TGAb levels were detected in 60.4% of those with highly 
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elevated TSH (>10 U/ml), 23.6% of those with elevated TSH (5.5-10 U/ml), and 
39.3% with low TSH (<0.35 U/ml), compared to only 15.9% of the children with 
normal TSH levels (0.35-5.5 U/ml) (6). Even though the reference ranges of TSH 
concentrations vary among studies, these previous studies show the association with 
abnormal TSH concentration and the increased prevalence of antithyroid antibody. 
 Mounting evidence indicates that subclinical thyroid dysfunction has 
important clinical effects and prognostic implications. Subclinical hypothyroidism has 
been associated with an increased risk for coronary and other heart disease and 
peripheral arterial disease, various biochemical abnormalities, including elevated low 
density lipoprotein cholesterol and depression. In addition, the major concern is the 
development of overt hypothyroidism over time. The annual risk for developing overt 
hypothyroidism after 20 years is 4.3% in women with increased TSH concentrations 
and antithyroid antibody and 2.6% in women with subclinical hypothyroidism without 
thyroid antibodies (7). This also indicates the value of examining antithyroid antibody 
in young people.  
 The influence of subclinical hyperthyroidism on health is not yet clear. 
However, evidence is accumulating that it has clinical importance, such as adverse 
effects on cardiac function, and more significantly, a higher incidence of arterial 
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fibrillation and a decrease in bone density. Furthermore, subclinical hyperthyroidism 
may be associated with disproportionate mortality. Biondi et al. showed that early 
treatment of persistent endogenous subclinical hyperthyroidism should be considered 
not only in the elderly but also in the young and middle-aged to improve their quality 
of life and avoid the consequences of long-term exposure of the cardiovascular system 
to small increases in thyroid hormone (8). In addition, children with hyperthyroidism 
usually present with behavioral disturbances such as attention problems, difficulty in 
concentration, and hyperactivity, which may lead to poor cognitive performance (9). 
However, attention disturbances in children with hyperthyroidism become attenuated 
once euthyroidism is achieved through treatment (10). These results suggest the 
necessity to detect subclinical thyroid dysfunction at an early age. 
In conclusion, we examined the serum TSH level and the prevalences of 
TPOAb and TGAb among children and young adults in a relatively large cohort. We 
found that the prevalence of TPOAb was significantly different in TSH concentrations 
less than 0.4 U/ml and more than 4.0 U/ml, and that the prevalence of TGAb was 
significantly different in TSH concentrations less than 0.4 U/ml compared to normal 
serum TSH concentrations in females. On the other hand, there were no significant 
differences in prevalences of TPOAb and TGAb among TSH concentrations in males. 
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The early identification of patients whose thyroid function might progress to overt 
hypo- and hyperthyroidism is important. We recommend that patients with values 





1. Hunter I, Greene SA, MacDonald TM, Morris A. Prevalence and aetiology of 
hypothyroidism in the young. Arch Dis Child 2000;83:207-10. 
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease 
Prevalence Study. Arch Intern Med 2000;160:526-34. 
3. Loviselli A, Velluzzi F, Mossa P, Cambosu MA, Secci G, Atzeni F, et al. The Sardinian 
autoimmunity study:3. Studies on circulating TA in Sardinian schoolchildren: Relationship 
to goiter prevalence and thyroid function. Thyroid 2001;11:849-57. 
4. Hollowell JG, Staehling NW, Flanders D, Hannon WH, Gunter EW, Spencer CA, 
Braverman LE 2002 Serum TSH, T4, and thyroid antibodies in the United States 
population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES 
III). J Clin Endocrinol Metab 87:489-499. 
5. Kaloumenou I, Mastorakos G, Alevizaki M, Duntas LH, Mantzou E, Ladopoulos C, et al. 
Gender, age, puberty, and BMI related changes of TSH and thyroid hormones in 
schoolchildren living in a long-standing iodine replete area. Thyroid 2008;18:747-54. 
6. Lazar L, Frumkin RB, Battat E, Lebenthal Y, Phillip M, Meyerovitch J. Natural history of 




7. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The 
incidence of thyroid disorders in the community: a twenty year follow-up of the 
Whickham survey. Clin Endocrinol 1995;43:55-68. 
8. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, et al. Endogenous 
subclinical hyperthyroidism affects quality of life and cardiac morphology and function in 
young and middle-aged patients. J Clin Endocrinol Metab 2000;85:4701-5. 
9. Alvarez MA, Gómez A, Alavez E, Navarro D. Attention disturbance in Graves’ Disease. 
Psyconeuroendocrinology 1983;8:451-4. 
10. Alvarez MA, Guell R, Chong D, Rovet J. Attention processing in hyperthyroid children 






Figure 1: Comparison of the prevalence of positive TPOAb in TSH concentrations divided by 
serum TSH concentrations; less than 0.4 U/ml, normal serum TSH concentrations (between 




Figure 2: Comparison of the prevalence of positive TGAb in TSH concentrations divided by 
serum TSH concentrations; less than 0.4 U/ml, normal serum TSH concentrations (between 
0.4 and 4.0 U/ml), and more than 4.0 U/ml. 
 
